| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| alrn-6924 | ubiquitin-protein ligase e3 mdm2 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Hematologic Neoplasms[MeSHID:D019337] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 2 | unknown |
| alrn-6924 | p53-binding protein mdm4 | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] MYELODYSPLASTIC SYNDROME[MeSHID:D009190] Leukemia Myelocytic Acute[MeSHID:D015470] Hematologic Neoplasms[MeSHID:D019337] Malignant Neoplasms[MeSHID:D009369] |
NA | phase 2 | unknown |
| click here to return to the previous page | ||||||||